Preferred Label : pseudolymphoma;

MeSH definition : A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed);

MeSH synonym : lymphoid hyperplasia, reactive; reactive lymphoid hyperplasia; reactive lymphoid hyperplasias; pseudolymphomas; lymphocytoma; lymphocytomas; hyperplasia, reactive lymphoid; hyperplasias, reactive lymphoid; lymphoid hyperplasias, reactive;

MeSH annotation : non-neoplastic; coord IM with organ/dis (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Pseudolymphoma;

Details


Main resources

You can consult :

A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed)

http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=60026
2014
false
true
false
France
scientific and technical information
hyperplasia
lung
pseudolymphoma

---
http://www.dermis.net/dermisroot/fr/22496/diagnose.htm
false
true
false
Germany
image
scientific and technical information
pseudolymphoma

---
http://www.dermis.net/dermisroot/fr/22530/diagnose.htm
false
true
false
Germany
diagnosis, differential
benign lymphocytic infiltration of jessner
image
scientific and technical information
pseudolymphoma

---
http://www.dermis.net/dermisroot/fr/22429/diagnose.htm
Germany
French
pseudolymphoma
scientific and technical information
image

---
https://www.therapeutique-dermatologique.org/spip.php?article1205
2008
France
scientific and technical information
benin
pseudolymphoma

---
Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.